Overview
The SARS-CoV-2 Spike receptor binding domain, RBD (395-430) – Lys(Biotin-LC) is a crucial peptide sequence for researchers focusing on coronavirus studies. This peptide is derived from the spike protein of SARS-CoV-2, specifically the receptor binding domain (RBD) composed of residues 395 to 430. Labeled with Biotin-LC at the C-terminus, this product serves as an invaluable tool for various applications including detection and binding studies related to SARS-CoV-2 and its interactions with human receptors. If you’re exploring the nuances of viral entry mechanisms or developing diagnostic assays, this peptide is a must-have for your research toolkit.
Key Features
- Biotin-LC labeling allows for easy detection and purification.
- Specific peptide sequence enhances specificity in binding studies.
- Essential for studying the spike protein’s role in cell entry.
- Available in a convenient 0.1 mg quantity.
- Quality assured for research and diagnostic applications.
Specifications
| Property | Details |
|---|---|
| Sequence | RBD (395-430) |
| Modification | Lys(Biotin-LC) |
| Quantity | 0.1 mg |
| Category | Peptides |
FAQ
What is the significance of the RBD peptide?
The RBD peptide plays a critical role in the virus’s ability to bind to the ACE2 receptor in human cells. This interaction is vital for understanding the mechanism of infection and for developing vaccines and therapeutics.
How can I use this peptide in my research?
This peptide can be used in binding assays, ELISA, or for producing labeled proteins that can further help in studying the interaction between the virus and human cells. You may also consider combining it with products like PKG Substrate for enhanced functionality.
Is this peptide suitable for diagnostic applications?
Yes, the SARS-CoV-2 Spike RBD peptide is suitable for various diagnostic applications and can be particularly useful in the development of assays aimed at detecting antibodies against SARS-CoV-2. For broader peptide options, check out our range of peptides.




Reviews
There are no reviews yet.